Eikon Therapeutics
4 employees
Biotech
Series D · $1.2B
Open positions (15)
Company details
Team Size4
IndustryBiotech
Funding
Total raised
$1.2B
Last stage
Series D
Investors
The Column Group
Total raised
$1.2B
Last stage
Series D
Investors
Eric Betzig
Nobel Prize-winning physicist (Chemistry, 2014) and UC Berkeley scientist who pioneered super-resolution fluorescence microscopy.
Robert Tjian
Biochemist at the University of California, Berkeley and former President of the Howard Hughes Medical Institute.
Xavier Darzacq
Served as interim CTO during the company's first year; scientist involved in live-cell imaging research.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.